https://presidiopartners.com/news/neos-therapeutics-completes-20-6-million-financing-to-further-advance-its-late-stage-adhd-product-pipeline/2017-01-27T10:27:56-08:00https://presidiopartners.com/news/technology-improves-yield-under-both-periodic-and-severe-water-stress/2017-01-27T10:47:42-08:00https://presidiopartners.com/news/wildcat-discovery-technologies-doe-vehicle-technologies-award-generates-promising-si-anode-electrolyte-leads/2017-01-27T11:57:42-08:00https://presidiopartners.com/news/neos-therapeutics-announces-submission-of-a-new-drug-application-for-its-methylphenidate-extended-release-oral-disintegrating-tablet-xr-odt-for-the-treatment-of-adhd/2017-01-27T10:28:41-08:00https://presidiopartners.com/news/neos-therapeutics-announces-issuance-of-key-patent-covering-its-extended-release-oral-disintegrating-tablet-xr-odt-platform-technology/2017-01-27T10:31:55-08:00https://presidiopartners.com/news/jobvite-secures-25-million-of-expansion-capital-led-by-catalyst-investors/2017-01-27T12:00:44-08:00https://presidiopartners.com/news/arcadia-biosciences-and-arborgen-to-develop-drought-tolerant-and-nitrogen-efficient-eucalyptus-trees/2017-01-27T10:49:56-08:00https://presidiopartners.com/news/neos-therapeutics-acquires-all-commercialization-and-profit-rights-to-generic-tussionex-extended-release-hydrocodone-polistirexchlorpheniramine-polistirex-from-chiesi-usa-and-coating-place-i/2017-01-27T10:32:09-08:00https://presidiopartners.com/news/petrobras-and-foro-energy-announce-signing-of-technology-cooperation-agreement/2017-01-27T11:59:24-08:00https://presidiopartners.com/news/odyssey-logistics-technology-corp-odyssey-announces-the-acquisition-of-ads-logistics/2017-01-27T12:03:37-08:00https://presidiopartners.com/news/arcadia-biosciences-receives-u-s-patent-for-extended-shelf-life-tomatoes/2017-01-27T10:53:04-08:00https://presidiopartners.com/news/neos-therapeutics-announces-positive-phase-3-study-results-for-its-methylphenidate-extended-release-xr-oral-disintegrating-tablet-odt-in-adhd-patients/2017-01-27T10:33:38-08:00https://presidiopartners.com/news/velocity-pharmaceutical-development-llc-and-tigercat-pharma-inc-announce-regulatory-clearance-for-initiating-phase-ii-study-with-vpd-737-in-prurigo-nodularis/2017-01-27T11:45:36-08:00https://presidiopartners.com/news/ardelyx-announces-pricing-of-its-initial-public-offering/2017-01-27T11:42:35-08:00https://presidiopartners.com/news/arcadia-biosciences-launches-sonova-ultra-gla-safflower-oil/2017-01-27T11:09:48-08:00https://presidiopartners.com/news/neos-therapeutics-inc-announces-the-appointment-of-richard-i-eisenstadt-as-chief-financial-officer/2017-01-27T10:33:50-08:00https://presidiopartners.com/news/ardelyx-receives-25-million-milestone-from-astrazeneca-for-commencement-of-phase-2b-clinical-trial-of-tenapanor/2017-01-27T11:42:51-08:00https://presidiopartners.com/news/arcadia-biosciences-raises-33-million-series-d-investment/2017-01-27T11:09:56-08:00https://presidiopartners.com/news/adderall-up-neos-gets-18m-series-c-plus-20m-loan-deal-for-ad/2017-01-27T11:18:14-08:00https://presidiopartners.com/news/china-is-now-world-leader-in-graphene-and-carbon-nanotube-research/2017-01-27T11:25:15-08:00https://presidiopartners.com/news/neos-therapeutics-announces-20-million-loan-facility-and-updated-total-of-18-million-for-its-additional-series-c-financing/2017-01-27T10:34:19-08:00https://presidiopartners.com/news/auspex-announces-completion-of-initial-public-offering/2017-01-27T11:29:40-08:00https://presidiopartners.com/news/teva-reinforces-leadership-position-in-cns-with-acquisition-of-auspex/2017-01-27T11:30:02-08:00https://presidiopartners.com/news/velocity-pharmaceutical-development-llc-and-tigercat-pharma-inc-announce-phase-2-results-for-vpd-737-in-patients-with-chronic-pruritus/2017-01-27T11:45:54-08:00https://presidiopartners.com/news/presidio-partners-announces-new-fund-unveils-new-corporate-identity-and-announces-additional-senior-management/2017-01-26T14:40:13-08:00https://presidiopartners.com/news/cnano-technology-limited-completes-15-million-series-c-financing/2017-01-27T11:20:14-08:00https://presidiopartners.com/news/surgiquest-names-jaime-landman-m-d-chief-medical-director/2017-01-27T11:35:59-08:00https://presidiopartners.com/news/neos-therapeutics-inc-appoints-thomas-p-mcdonnell-as-chief-commercial-officer/2017-01-27T10:26:35-08:00https://presidiopartners.com/news/neos-therapeutics-announces-trade-name-cotempla-xr-odt-for-its-methylphenidate-extended-release-orally-disintegrating-tablets/2017-01-27T10:38:17-08:00https://presidiopartners.com/news/baxter-ventures-mayo-clinic-and-velocity-pharmaceutical-development-announce-the-formation-of-vitesse-biologics-llc-a-company-structured-to-accelerate-therapeutic-innovation/2017-01-27T11:46:11-08:00https://presidiopartners.com/news/ardelyx-regains-worldwide-development-and-commercialization-rights-for-its-late-stage-development-candidate-tenapanor-and-related-portfolio-of-nhe3-compounds/2017-01-27T11:41:24-08:00https://presidiopartners.com/news/neos-therapeutics-announces-pricing-of-initial-public-offering/2017-01-27T10:24:33-08:00https://presidiopartners.com/news/flex-to-expand-its-solar-offering-by-adding-innovative-solar-tracking-solutions-through-the-strategic-acquisition-of-nextracker/2017-01-27T12:02:06-08:00https://presidiopartners.com/news/conmed-announces-definitive-agreement-to-acquire-surgiquest-inc/2017-01-27T11:36:18-08:00https://presidiopartners.com/news/marlin-equity-partners-to-acquire-liveops-cloud-platform-business/2017-01-27T10:18:42-08:00https://presidiopartners.com/news/conmed-completes-acquisition-of-surgiquest-inc/2017-01-27T11:36:09-08:00https://presidiopartners.com/news/neos-therapeutics-announces-fda-approval-of-adzenys-xr-odt/2017-01-27T10:24:06-08:00https://presidiopartners.com/news/odyssey-logistics-technology-posts-earnings-growth-of-18-percent/2017-01-27T12:03:16-08:00https://presidiopartners.com/news/ensemble-therapeutics-announces-global-pharma-partner-expands-access-to-il-17-assets/2017-01-31T09:54:18-08:00https://presidiopartners.com/news/inventure-announces-partnership-with-mazzoni-to-process-refinery-by-product-lipid-into-value-added-oleochemicals/2017-01-27T11:53:01-08:00https://presidiopartners.com/news/liveops-appoints-chief-operating-officer/2017-01-27T10:17:50-08:00https://presidiopartners.com/news/untangle-announces-acquisition-by-providence-equity/2017-01-27T11:50:49-08:00https://presidiopartners.com/news/liveops-cloud-becomes-serenova-simplifies-customer-experience/2017-01-27T11:49:59-08:00https://presidiopartners.com/news/menlo-therapeutics-recruits-experienced-management-team-and-board-leadership-to-accelerate-development-of-serlopitant-for-treatment-of-pruritus/2017-02-02T13:17:48-08:00https://presidiopartners.com/news/liveops-appoints-new-ceo-to-lead-contact-center-bpo-business/2017-01-26T14:15:47-08:00https://presidiopartners.com/news/mojo-networks-closes-30-million-to-fuel-growth-and-further-disrupt-the-wifi-networking-industry/2017-02-09T11:48:01-08:00https://presidiopartners.com/news/petrobras-and-foro-energy-announce-signing-extension-of-technology-cooperation-agreement/2017-02-17T14:22:33-08:00https://presidiopartners.com/news/menlo-therapeutics-announces-successful-pruritus-reduction-results-from-phase-2-serlopitant-trial-tcp-102-in-127-subjects-with-prurigo-nodularis/2017-03-08T11:31:07-08:00https://presidiopartners.com/news/mojo-networks-the-age-of-cognitive-wifi-cio-review/2017-07-10T12:07:31-08:00https://presidiopartners.com/news/a123-systems-completes-5m-equity-investment-in-wildcat-discovery-technologies/2017-07-10T12:10:18-08:00https://presidiopartners.com/news/dianrong-acquires-asset-origination-operations-of-quark-finance-dianrong-focus-special-report/2017-07-14T11:55:07-08:00https://presidiopartners.com/news/soligent-to-distribute-solaria-powerxt-modules-nationwide/2017-07-14T11:57:29-08:00https://presidiopartners.com/news/menlo-therapeutics-raises-50m/2017-07-19T09:05:48-08:00https://presidiopartners.com/news/singapores-gic-leads-220-million-funding-round-for-chinese-p2p-lender-dianrong/2017-08-23T14:26:10-08:00https://presidiopartners.com/news/press-releases-odyssey-logistics-technology-receives-equity-investment-from-the-jordan-company/2017-12-05T11:05:07-08:00https://presidiopartners.com/news/dianrong-names-executive-chairman-co-chairman-and-ceo/2018-01-12T15:38:42-08:00https://presidiopartners.com/news/solaria-raises-23-million-in-funding-to-expand-manufacturing-of-its-breakthrough-solar-modules-pdf/2018-01-12T15:50:49-08:00https://presidiopartners.com/news/corsair-pharma-and-united-therapeutics-enter-into-strategic-collaboration-to-advance-novel-treprostinil-prodrugs/2018-01-12T17:02:36-08:00https://presidiopartners.com/news/menlo-therapeutics-announces-pricing-for-initial-public-offering/2018-02-12T10:18:48-08:00https://presidiopartners.com/news/arista-acquires-mojo-networks/2018-08-02T12:17:34-08:00https://presidiopartners.com/news/inventure-renewables-wilmar-and-desmet-ballestra-announce-agreement-to-build-new-plant/2018-08-07T12:05:34-08:00https://presidiopartners.com/news/altimmune-announces-closing-of-acquisition-of-spitfire-pharma/2019-09-14T10:53:09-08:00https://presidiopartners.com/news/solaria-raises-40m-to-double-its-module-production-capacity/2020-04-05T15:51:17-08:00https://presidiopartners.com/news/ardelyx-receives-fda-approval/2019-12-07T14:10:03-08:00https://presidiopartners.com/news/wildcat-raises-more-than-20m-series-c-financing/2019-12-07T14:13:15-08:00https://presidiopartners.com/news/lifesize-and-serenova-merge/2020-04-05T15:50:11-08:00https://presidiopartners.com/news/altimmune-completes-first-development-milestone-toward-a-single-dose-intranasal-covid-19-vaccine/2020-04-05T15:45:11-08:00https://presidiopartners.com/news/solaria-corporation-unveils-world-class-executive-team/2020-06-08T18:23:29-08:00https://presidiopartners.com/news/exela-secure-investments-for-us-drug-supply-manufacturing/2021-09-23T06:45:16-08:00https://presidiopartners.com/news/wildcat-discovery-technologies-welcomes-dr-peter-lamp-as-new-board-member/2026-08-19T09:08:28-08:00https://presidiopartners.com/news/wildcat-discovery-technologies-raises-more-than-90-million-in-series-d-financing-for-commercialization-of-an-ev-super-cell/2026-08-19T09:11:54-08:00https://presidiopartners.com/news/wildcat-discovery-signs-joint-development-agreement-with-bmw-group-to-speed-next-generation-battery-technology-to-the-market/2026-08-19T09:13:21-08:00https://presidiopartners.com/news/wildcat-discovery-technologies-receives-its-100th-patent/2026-08-19T09:14:57-08:00https://presidiopartners.com/news/wildcat-expands-its-battery-development-center-and-enhances-its-rd-offerings/2026-08-19T09:19:29-08:00https://presidiopartners.com/news/wildcat-discovery-technologies-and-energyx-announce-joint-venture-for-15000-ton-commercial-lfp-cathode-manufacturing-facility-in-texas/2026-08-19T09:20:41-08:00